Search - tctmd.com

Displaying 21 - 40 of 73

Sort: Relevancy | Date

News Conference News TCT 2015

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

October 13, 2015

Presentation TCT 2015

Update on Biolimus-Eluting Stent Platforms: BioMatrix and Nobori Program Update

Presenter: Stephen G. Ellis, John A. Ormiston, Philip M. Urban

October 11, 2015

News Daily News

Un Meta Análisis Confirma la Seguridad Tardía de los SLF de 2ª Generación

L.A. McKeown

June 10, 2015

News Daily News

Meta-analysis Confirms Late Safety of Second-Generation DES

L.A. McKeown

June 10, 2015

News Daily News

EVERBIO II Published: BVS Matches Leading DES for Midterm Outcomes

L.A. McKeown

February 26, 2015

News Daily News

含可生物降解聚合物的 DES 可安全使用、耐用长达 5 年

L.A. McKeown

January 28, 2015

News Daily News

Los SLF con Polímero Biodegradable son Seguros y Duraderos al cabo de 5 Años

L.A. McKeown

January 28, 2015

News Daily News

DES With Biodegradable Polymer Safe, Durable Through 5 Years

L.A. McKeown

January 28, 2015

News Daily News

SECURITY: 6 Months of DAPT Noninferior to 12 Months in Low-Risk Patients After PCI

Yael L. Maxwell

November 17, 2014

News Daily News

SECURITY: 6 Meses de Terapia Antiplaquetaria Doble No son Inferiores a 12 Meses en Pacientes de Bajo Riesgo Post-PCI

Yael L. Maxwell

November 17, 2014

News Daily News

SECURITY：在PCI后的低风险患者中，6个月DAPT相对于12个月的该策略具有非劣效性

Yael L. Maxwell

November 17, 2014

News Daily News

研究证实采用较新DES时支架内血栓形成和心肌梗死风险降低

Salynn Boyles

November 02, 2014

News Daily News

Un Estudio Confirma Menor Riesgo de Trombosis del Stent,IM con los Nuevos SLF

Salynn Boyles

November 02, 2014

News Daily News

Study Confirms Lower Stent Thrombosis, MI Risks With Newer DES

Salynn Boyles

November 02, 2014

News Conference News TCT 2014

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

September 17, 2014

Presentation TCT 2014

2-year outcomes and angiograms from the bifurcation subgroup of the e-BioMatrix registry

Presenter: Keith Oldroyd

September 16, 2014

Presentation TCT 2014

Safety and Efficacy Profile of BioMatrix and Nobori in Simple and Complex Lesions: Global Program Overview

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stephan Windecker

September 15, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

News Conference News TCT 2014

OCT STEMI: Imaging-Guided PCI Shows Promise

September 14, 2014

News Conference News ESC 2014

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Todd Neale

September 02, 2014

Advertisement

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

Update on Biolimus-Eluting Stent Platforms: BioMatrix and Nobori Program Update

Un Meta Análisis Confirma la Seguridad Tardía de los SLF de 2ª Generación

Meta-analysis Confirms Late Safety of Second-Generation DES

EVERBIO II Published: BVS Matches Leading DES for Midterm Outcomes

含可生物降解聚合物的 DES 可安全使用、耐用长达 5 年

Los SLF con Polímero Biodegradable son Seguros y Duraderos al cabo de 5 Años

DES With Biodegradable Polymer Safe, Durable Through 5 Years

SECURITY: 6 Months of DAPT Noninferior to 12 Months in Low-Risk Patients After PCI

SECURITY: 6 Meses de Terapia Antiplaquetaria Doble No son Inferiores a 12 Meses en Pacientes de Bajo Riesgo Post-PCI

SECURITY：在PCI后的低风险患者中，6个月DAPT相对于12个月的该策略具有非劣效性

研究证实采用较新DES时支架内血栓形成和心肌梗死风险降低

Un Estudio Confirma Menor Riesgo de Trombosis del Stent,IM con los Nuevos SLF

Study Confirms Lower Stent Thrombosis, MI Risks With Newer DES

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

2-year outcomes and angiograms from the bifurcation subgroup of the e-BioMatrix registry

Safety and Efficacy Profile of BioMatrix and Nobori in Simple and Complex Lesions: Global Program Overview

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

OCT STEMI: Imaging-Guided PCI Shows Promise

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content